MedTrace Logo

A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression

NCT00676793 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2017-09-21

Study results available
· View outcomes & findings →

Summary

To see if an extract of green tea can affect certain markers of breast cancer and breast cancer progression in women with a recent biopsy positive for cancer and who are scheduled for surgery.

Conditions

Interventions

DRUG

Polyphenon E

Four 200mg capsules daily taken with a meal, for the duration of the study.

Sponsors & Collaborators

  • Columbia University

    collaborator OTHER

  • Louisiana State University Health Sciences Center Shreveport

    lead OTHER

Principal Investigators

  • Gary Burton, M.D. · LSU Health Sciences Center Shreveport

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Primary Completion
2009-12-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00676793 on ClinicalTrials.gov